DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn

Developed marketing strategy which lead to $12 million USD in private financing

Clifford L. Hendrick, MBA | Corporate Strategy

Cliff Hendrick is the Founder of Aquila Executive Services, a consulting firm specializing in business strategy, portfolio management and executive support for start-up and early development stage companies. Cliff’s executive leadership experience includes serving as the Vice President and General Manager of Early Development for the Oncology business at Genzyme Corp., a biotechnology leader in cancer research. Throughout his career he has been involved in research and development, operations, program and alliance management, and business development.

Cliff joined Genzyme in 1989 through its merger with Integrated Genetics. Prior to assuming his latest position, he had served as Vice President, Operations for Genzyme Oncology and for Genzyme Molecular Oncology since its formation in June 1997. At Genzyme, he oversaw program and alliance management for the Oncology business unit, including small molecule and antibody-based therapies, and advanced six candidates into early stage clinical trials. He managed strategic partnerships with both Kirin Pharmaceuticals and Purdue Pharma, representing $25MM in research funding/milestones.

His career includes working with Integrated Genetics and Millipore Corporation, holding leadership positions in research and development and operations. He was a member of the Management Advisory Board of Signet Laboratories until its acquisition by Covance Inc. and is a former Board Member of the New England Regional Chapter of the Association of Strategic Alliance Professionals.

Cliff holds a B.S. in Life Science from the Massachusetts Institute of Technology and an M.B.A. from Northeastern University.



"Cori Gorman has an extraordinarily high level of expertise, which was one of the critical factors in choosing her for this. When things come up again, she is the person I will go to."

- Senior scientist at a biotechnology company.

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.